Literature DB >> 27496000

Editorial overview: New technologies: GPCR drug design and function-exploiting the current (of) structures.

Christofer S Tautermann1, David E Gloriam2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27496000     DOI： 10.1016/j.coph.2016.07.012

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


× No keyword cloud information.
  5 in total

1.  Machine Learning for Prioritization of Thermostabilizing Mutations for G-Protein Coupled Receptors.

Authors:  Sanychen Muk; Soumadwip Ghosh; Srisairam Achuthan; Xiaomin Chen; XiaoJie Yao; Manbir Sandhu; Matthew C Griffor; Kimberly F Fennell; Ye Che; Veerabahu Shanmugasundaram; Xiayang Qiu; Christopher G Tate; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2019-10-24       Impact factor: 4.033

Review 2.  Trends in GPCR drug discovery: new agents, targets and indications.

Authors:  Alexander S Hauser; Misty M Attwood; Mathias Rask-Andersen; Helgi B Schiöth; David E Gloriam
Journal:  Nat Rev Drug Discov       Date:  2017-10-27       Impact factor: 84.694

Review 3.  An online resource for GPCR structure determination and analysis.

Authors:  Christian Munk; Eshita Mutt; Vignir Isberg; Louise F Nikolajsen; Janne M Bibbe; Tilman Flock; Michael A Hanson; Raymond C Stevens; Xavier Deupi; David E Gloriam
Journal:  Nat Methods       Date:  2019-01-21       Impact factor: 28.547

4.  Identifying GPCR-drug interaction based on wordbook learning from sequences.

Authors:  Pu Wang; Xiaotong Huang; Wangren Qiu; Xuan Xiao
Journal:  BMC Bioinformatics       Date:  2020-04-20       Impact factor: 3.169

5.  GPCRdb in 2018: adding GPCR structure models and ligands.

Authors:  Gáspár Pándy-Szekeres; Christian Munk; Tsonko M Tsonkov; Stefan Mordalski; Kasper Harpsøe; Alexander S Hauser; Andrzej J Bojarski; David E Gloriam
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.